Fibromyalgia Health Outcome Study on Cost of Treatments - NCT00725101-46260 (Clinical Trial 234211)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy234211.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Indianapolis |
|
State:
|
|
IN |
| Zip Code: |
|
46260 |
| Conditions: |
|
Fibromyalgia |
| Purpose: |
|
The REFLECTIONS Study is a 12-month, prospective observational study that will be utilized
in approximately 100 care settings in the United States (US) and Puerto Rico. It is
designed to examine treatment patterns and health outcomes of adult patients diagnosed by
their physician with fibromyalgia (FM) and who are starting any "new pharmacologic agent"
for FM.
The primary benefit of this study is enhanced understanding of the disease state of FM and
the role that pharmacologic treatment plays, which may help to optimize the management of
FM. This study will address current gaps in a rapidly growing body of literature for FM.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Meet criteria for FM, in the opinion of the investigator
- Must be prescribed a 'new' treatment for FM
- Male and female patients at least 18 years of age
- Willing to complete the ICD form and any other required forms to be eligible for
participation in the study
- Currently under the care of the participating physician
- Cognitively able to understand and complete patient self-rated scales in English or
Spanish via CATI
- Available for 12 months to participate in the study
Exclusion Criteria:
- Are investigator site personnel directly affiliated with the study and/or their
immediate families. Immediate family is defined as a spouse, parent, child, or
sibling, whether biological or legally adopted
- Are Lilly employees
- Terminally ill
- Currently participating in other research studies or if they begin a research study
while participating in this study
- Unable to respond via telephone for CATI
- Incompetent for interview as deemed by the participating physician
- Unwilling to provide written Informed Consent or other required forms to participate
in the study |
|
|
|
| Study is available at: |
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Indianapolis, IN 46260
United States
Primary Contact:
There may be multiple sites in this clinical trial 1-877-CTLILLY (1-877-285-4559)
Phone: 1-317-615-4559 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|